Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled Trial
| Title: | Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled Trial |
|---|---|
| Authors: | Madden, StuartAff1, IDs40263025011980_cor1; Awad, IssamAff2; Lopez-Toledano, Miguel A.Aff1, Aff3; Morrison, LeslieAff4; Gutierrez, JuanAff5; Ngo, Leock Y.Aff1; Carrazana, EnriqueAff1, Aff6; Rabinowicz, Adrian L.Aff1, Aff3 |
| Source: | CNS Drugs. 39(9):865-877 |
| Database: | Springer Nature Journals |